Alex Morgan
Partner at Khosla Ventures
Palo Alto, California
Writes $500K – $50M checks · typically $25M
About
Alexander Morgan, an MD/PhD physician-scientist with 25 years at the AI–biotech–healthcare intersection, oversees biotech and healthcare investing with an AI/ML emphasis and is one of the most active neurotech investors.
Alexander A. Morgan, MD PhD @genomicsdoc
This is a real step function level improvement in the capability of AI driven drug design. @nablabio is able to fully design a multifunctional/multispecific biologic de novo. This is the way to get to N of 1 personalized biologics. https://t.co/6uqfjUsPdE
Jun 24, 2026 · ♥ 10 · ⇄ 1
Alexander A. Morgan, MD PhD @genomicsdoc
Great piece of visual design. https://t.co/pWoAnGOsYu
Jun 22, 2026 · ♥ 4 · ⇄ 1
Alexander A. Morgan, MD PhD @genomicsdoc
We at @khoslaventures are excited about what @sleepdiplomat is doing, and how AI and data can be used to improve the sleep for everyone. https://t.co/uCNTIZh83j
Jun 17, 2026 · ♥ 2 · ⇄ 1
Invests in
AI & Machine LearningBiotechClimate TechData & InfrastructureDigital HealthEnterprise SoftwareHealthtech
Deals · 5
Faeth TherapeuticsBoard seat
via Khosla Ventures · filed Jan 2026 · $25M raise
VivodyneBoard seat
via Khosla Ventures · filed Jun 2025 · $77.7M raise
Viome Life SciencesBoard seat
via Khosla Ventures · filed Aug 2024 · $30M raise
SynchronBoard seat
via Khosla Ventures · filed Dec 2022 · $86M raise
PrellisbioBoard seat
via Khosla Ventures · filed Jul 2022 · $35M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Khosla Ventures
Network16
▶4 more connections
Investors connected to Alex in public investor directories — a warm-intro map.